Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion.
X. Manz (Amsterdam, Netherlands), X. Pan (Amsterdam, Netherlands), P. Symersky (Amsterdam, Netherlands), J. Majolée (Amsterdam, Netherlands), P. Hordijk (Amsterdam, Netherlands), J. Voorberg (Amsterdam, Netherlands), J. Aman (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands), R. Szulcek (Amsterdam, Netherlands)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Session: Chronic thromboembolic pulmonary hypertension
Session type: E-poster session
Number: 1551
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Manz (Amsterdam, Netherlands), X. Pan (Amsterdam, Netherlands), P. Symersky (Amsterdam, Netherlands), J. Majolée (Amsterdam, Netherlands), P. Hordijk (Amsterdam, Netherlands), J. Voorberg (Amsterdam, Netherlands), J. Aman (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands), R. Szulcek (Amsterdam, Netherlands). Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion.. 1551
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Response of plasma von Willebrand factor to systemic endothelial injury in pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 545s Year: 2006
Expression of CD 34 and von Willebrand factor in pulmonary endothelium Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001
Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002
Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004
Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009
Changes of plasma von Willebrand factor in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
Platelet function in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009
Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction? Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003
Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008
Endothelin, endothelial cells and von Willenbrandt factor in peripheral blood in asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003
Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015
P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010
Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension}, Source: Eur Respir J 2012; 40: 886-894 Year: 2012
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017
Pulmonary artery endothelial cell secretion of factor VIII Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008
Is pulmonary hypertension associated with a leakage or an activation of endothelial cells? Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003
Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010
Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 736-741 Year: 2008
Prognoctic value of platelet factor-4 and thrombin-antithrombin complex for pulmonary hypertension among patients with idiopathic interstitial pneumonias Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006
Endothelial and platelet dysfunction in pulmonary hypertension due to sarcoidosis Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008